S Biomedics Co (XKRX:304360) Total Equity : ₩11,124 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co Total Equity?

S Biomedics Co's total equity for the quarter that ended in Mar. 2024 was ₩11,124 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

S Biomedics Co Total Equity Historical Data

The historical data trend for S Biomedics Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co Total Equity Chart

S Biomedics Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Equity

Get a 7-Day Free Trial

15,264.13

12,739.16

4,799.70

3,831.61

1,035.03

S Biomedics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Equity	Get a 7-Day Free Trial															-843.07	15,507.68	13,821.50	12,274.83	11,124.42

S Biomedics Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

S Biomedics Co's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2022 )	-	Total Liabilities(Q: Dec. 2022 )
	=	24357.825	-	23322.796
	=	1,035

S Biomedics Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2024 )	-	Total Liabilities(Q: Mar. 2024 )
	=	30406.349	-	19281.932
	=	11,124

S Biomedics Co Total Equity Related Terms

Thank you for viewing the detailed overview of S Biomedics Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

S Biomedics Co (XKRX:304360) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797

Website

https://www.sbiomedics.com

S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines